|
Temozolomide Laboratory Investigations |
|
Home > Database
> Treatment
>
Temozolomide Laboratory Investigations
|
|
|
Contents
|
|
|
|
Basic
Science
|
|
|
|
|
Blough MD, Westgate MR, Beauchamp D, Kelly JJ, Stechishin O, Ramirez AL, Weiss S,
Cairncross JG.
Sensitivity to temozolomide in brain tumor initiating cells
Neuro Oncol. 2010 Apr 13;. [Epub ahead of print]
.JPG)
Abstract
|
|
|
Waldeck W, Wiessler M, Ehemann V, Pipkorn R,
Spring H, Debus J, Didinger B, Mueller G, Langowski J, Braun K.
TMZ-BioShuttle--a reformulated temozolomide
Int J Med Sci. 2008 Sep 15;5(5):273-84
Abstract | .png) Full text |
.png)
Reprint
|
|
|
Brain
Tumors
|
|
|
|
|
Maschio M, Albani F, Jandolo B, Zarabla A,
Contin M, Dinapoli L, Fabi A, Pace A, Baruzzi A
Temozolomide treatment does not affect topiramate and oxcarbazepine
plasma concentrations in chronically treated patients with brain
tumor-related epilepsy
J Neurooncol. 2008 Jul 9; [Epub ahead of print]
Abstract
|
|
Stupp
R, Gander M, Leyvraz S, Newlands E
Current
and future developments in the use of temozolomide for the treatment of
brain tumours
Lancet Oncol. 2001 Sep; 2(9): 552-60.
|
|
|
Tilleul
P, Brignone M, Hassani Y, Taillandier L, Taillibert S, Cartalat-Carel S,
Borget I, Chinot O.
Prescription guidebook for temozolomide usage in brain tumors
Bull Cancer. 2009 May 1;96(5):579-589. French
Abstract |
Full text |
Reprint
|
|
|
Cancer
Research
|
|
|
|
Pegg
AE
Mammalian
O6-alkylguanine-DNA alkyltransferase: regulation and importance in
response to alkylating carcinogenic and therapeutic agents
Cancer Res 1990 Oct 1;50(19):6119-29
|
|
|
Shinoura N, Yamada R, Tabei Y, Saito K, Nakamura
O, Takahashi M.
Temozolomide-temodal
Gan To Kagaku Ryoho. 2008 Mar;35(3):543-7
Abstract
|
|
|
Hum.
lymphobl. cell lines
|
|
|
|
D'Atri S, Tentori L, Lacal PM,
Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, Jiricny J
Involvement
of the mismatch repair system in temozolomide-induced apoptosis
Mol Pharmacol 1998 Aug;54(2):334-41 (PDF Full text)
|
|
|
Metastatic Tumors
|
|
|
|
Islam
R, Isaacson BJ, Zickerman PM, Ratanawong C, Tipping SJ
Hemorrhagic
cystitis as an unexpected adverse reaction to temozolomide: case report
Am J Clin Oncol 2002
Oct;25(5):513-4
|
|
Lucio Tentori, Carlo Leonetti, Marco Scarsella, Weizheng Xu,
David C. Calvin, Lisa Morgan, Zhaocheng Tang, Krystyna M. Wozniak, Christina
Alemu, Randall Hoover, Rena G. Lapidus, Gabriella Zupi, Jie Zhang, Grazia
Graziani
Oral administration of the PARP-1 inhibitor GPI 15427 increases
the anti-tumor activity of temozolomide against melanoma growing at the CNS site
Proceedings of the AACR, Volume 45, March 2004, Abstract
Number: 2007.
|
|
|
Anapl.
Oligoastrocytoma
|
|
|
|
Alfredo D. Voloschin,
David N. Louis, Garth R. Cosgrove, and Tracy T. Batchelor
Neoadjuvant temozolomide followed by complete resection of a 1p- and
19q-deleted anaplastic oligoastrocytoma: Case study
Neuro-Oncology, Volume
7, Number 1, Pages 97 -- 100, January 2005. (Abstract+)
|
|
